English
United States
Sign in
Tip from find-more-books.com
Similar books
More/other books that might be very similar to this book
Search tools
Book recommendations
Latest news
Advertising
FILTER
- 0 Results
Lowest price: 152.34 €, highest price: 190.85 €, average price: 164.03 €
Heart Failure
book is out-of-stock
(*)
Heart Failure - new book

ISBN: 9780470029329

ID: 9780470029329

Molecules, Mechanisms and Therapeutic Targets, No. 274 InhaltsangabeIntroduction (Eric N. Olson).Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation (Eric N. Olson, Johannes Backs and Timothy A. McKinsey) .Discussion.A novel mechanism of mechanical stress-induced hypertrophy (Hiroshi Akazawa, Yunzeng Zou and Issei Komuro) .Discussion.Controlling cardiomyocyte survival (N. de Jonge, M. J. Goumans, Daan Lips, Rutger Hassink, Eva J. Vlug, Roy van der Meel, Christopher Donald Emmerson, Joppe Nijman, Leon de Windt and Pieter A. Doevendans) .Discussion.Mechanisms of angiotensin II-dependent progression to heart failure (Mona Nemer, Nassim Dali-Youcef, Hao Wang, Anne Aries and Pierre Paradis) .Discussion.Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure (Matthew R. Taylor and Michael R. Bristow) .Discussion.Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy (Julie R. McMullen and Seigo Izumo).Discussion.Role of Akt in cardiac growth and metabolism(Anthony J. Muslin and Brian DeBosch).Discussion.Novel therapy for heart failure and exercise-induced ventricular tachycardia based on & #8216 fixing& #8217 the leak in ryanodine receptors (Andrew R. Marks).Discussion.General discussion I.Phospholamban as a therapeutic modality in heart failure (Guoxiang Chu and Evangelia G. Kranias).Discussion.Sarcomere protein gene mutations and inherited heart disease: a b-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure (Mitsuhiro Kamisago, Joachim P. Schmitt, Dennis McNamara, Christine Seidman and Jonathan G. Seidman).Discussion.The cardiomyocyte cell cycle (Pascal J. E. Lafontant and Loren J. Field).Discussion.Restoration of cardiac function with progenitor cells (Carmen Urbich, Lothar R& #246 ssig and Stefanie Dimmeler).Discussion.Signalling pathways in cardiac regeneration (Maria Paola Santini, Nadine Winn and Nadia Rosenthal).Discussion.Beyond small molecule drugs for heart failure: prospects for gene therapy (Kenneth R. Chien).Discussion.Dual roles of telomerase in cardiac protection and repair (Michael D. Schneider).Discussion.Final general discussion.Closing remarks: historical perspective (Arnold M. Katz).Index of contributors.Subject index. Heart Failure: InhaltsangabeIntroduction (Eric N. Olson).Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation (Eric N. Olson, Johannes Backs and Timothy A. McKinsey) .Discussion.A novel mechanism of mechanical stress-induced hypertrophy (Hiroshi Akazawa, Yunzeng Zou and Issei Komuro) .Discussion.Controlling cardiomyocyte survival (N. de Jonge, M. J. Goumans, Daan Lips, Rutger Hassink, Eva J. Vlug, Roy van der Meel, Christopher Donald Emmerson, Joppe Nijman, Leon de Windt and Pieter A. Doevendans) .Discussion.Mechanisms of angiotensin II-dependent progression to heart failure (Mona Nemer, Nassim Dali-Youcef, Hao Wang, Anne Aries and Pierre Paradis) .Discussion.Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure (Matthew R. Taylor and Michael R. Bristow) .Discussion.Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy (Julie R. McMullen and Seigo Izumo).Discussion.Role of Akt in cardiac growth and metabolism(Anthony J. Muslin and Brian DeBosch).Discussion.Novel therapy for heart failure and exercise-induced ventricular tachycardia based on & #8216 fixing& #8217 the leak in ryanodine receptors (Andrew R. Marks).Discussion.General discussion I.Phospholamban as a therapeutic modality in heart failure (Guoxiang Chu and Evangelia G. Kranias).Discussion.Sarcomere protein gene mutations and inherited heart disease: a b-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure (Mitsuhiro Kamisago, Joachim P. Schmitt, Dennis McNamara, Christine Seidman and Jonathan G. Seidman).Discussion.The cardiomyocyte cell cycle (Pascal J. E. Lafontant and Loren J. Field).Discussion.Restoration of cardiac function with progenitor cells (Carmen Urbich, Lothar R& #246 ssig and Stefanie Dimmeler).Discussion.Signalling pathways in cardiac regeneration (Maria Paola Santini, Nadine Winn and Nadia Rosenthal).Discussion.Beyond small molecule drugs for heart failure: prospects for gene therapy (Kenneth R. Chien).Discussion.Dual roles of telomerase in cardiac protection and repair (Michael D. Schneider).Discussion.Final general discussion.Closing remarks: historical perspective (Arnold M. Katz).Index of contributors.Subject index. Biotechnologie Biotechnologie i. d. Biowissenschaften Biotechnology Biowissenschaften Cardiovascular Disease Cell & Molecular Biology Kardiovaskuläre Erkrankungen Life Sciences Medical Science Medizin Zell- u. Molekularbiologie, John Wiley & Sons

New book Rheinberg-Buch.de
Ebook, Englisch, Neuware Shipping costs:Ab 20¤ Versandkostenfrei in Deutschland, Sofort lieferbar, DE. (EUR 0.00)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Heart Failure
book is out-of-stock
(*)
Heart Failure - new book

ISBN: 9780470029329

ID: 9780470029329

Molecules, Mechanisms and Therapeutic Targets, No. 274 InhaltsangabeIntroduction (Eric N. Olson).Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation (Eric N. Olson, Johannes Backs and Timothy A. McKinsey) .Discussion.A novel mechanism of mechanical stress-induced hypertrophy (Hiroshi Akazawa, Yunzeng Zou and Issei Komuro) .Discussion.Controlling cardiomyocyte survival (N. de Jonge, M. J. Goumans, Daan Lips, Rutger Hassink, Eva J. Vlug, Roy van der Meel, Christopher Donald Emmerson, Joppe Nijman, Leon de Windt and Pieter A. Doevendans) .Discussion.Mechanisms of angiotensin II-dependent progression to heart failure (Mona Nemer, Nassim Dali-Youcef, Hao Wang, Anne Aries and Pierre Paradis) .Discussion.Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure (Matthew R. Taylor and Michael R. Bristow) .Discussion.Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy (Julie R. McMullen and Seigo Izumo).Discussion.Role of Akt in cardiac growth and metabolism(Anthony J. Muslin and Brian DeBosch).Discussion.Novel therapy for heart failure and exercise-induced ventricular tachycardia based on ‘ fixing’ the leak in ryanodine receptors (Andrew R. Marks).Discussion.General discussion I.Phospholamban as a therapeutic modality in heart failure (Guoxiang Chu and Evangelia G. Kranias).Discussion.Sarcomere protein gene mutations and inherited heart disease: a b-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure (Mitsuhiro Kamisago, Joachim P. Schmitt, Dennis McNamara, Christine Seidman and Jonathan G. Seidman).Discussion.The cardiomyocyte cell cycle (Pascal J. E. Lafontant and Loren J. Field).Discussion.Restoration of cardiac function with progenitor cells (Carmen Urbich, Lothar Rö ssig and Stefanie Dimmeler).Discussion.Signalling pathways in cardiac regeneration (Maria Paola Santini, Nadine Winn and Nadia Rosenthal).Discussion.Beyond small molecule drugs for heart failure: prospects for gene therapy (Kenneth R. Chien).Discussion.Dual roles of telomerase in cardiac protection and repair (Michael D. Schneider).Discussion.Final general discussion.Closing remarks: historical perspective (Arnold M. Katz).Index of contributors.Subject index. Heart Failure: InhaltsangabeIntroduction (Eric N. Olson).Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation (Eric N. Olson, Johannes Backs and Timothy A. McKinsey) .Discussion.A novel mechanism of mechanical stress-induced hypertrophy (Hiroshi Akazawa, Yunzeng Zou and Issei Komuro) .Discussion.Controlling cardiomyocyte survival (N. de Jonge, M. J. Goumans, Daan Lips, Rutger Hassink, Eva J. Vlug, Roy van der Meel, Christopher Donald Emmerson, Joppe Nijman, Leon de Windt and Pieter A. Doevendans) .Discussion.Mechanisms of angiotensin II-dependent progression to heart failure (Mona Nemer, Nassim Dali-Youcef, Hao Wang, Anne Aries and Pierre Paradis) .Discussion.Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure (Matthew R. Taylor and Michael R. Bristow) .Discussion.Role of the insulin-like growth factor 1 (IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediating physiological cardiac hypertrophy (Julie R. McMullen and Seigo Izumo).Discussion.Role of Akt in cardiac growth and metabolism(Anthony J. Muslin and Brian DeBosch).Discussion.Novel therapy for heart failure and exercise-induced ventricular tachycardia based on ‘ fixing’ the leak in ryanodine receptors (Andrew R. Marks).Discussion.General discussion I.Phospholamban as a therapeutic modality in heart failure (Guoxiang Chu and Evangelia G. Kranias).Discussion.Sarcomere protein gene mutations and inherited heart disease: a b-cardiac myosin heavy chain mutation causing endocardial fibroelastosis and heart failure (Mitsuhiro Kamisago, Joachim P. Schmitt, Dennis McNamara, Christine Seidman and Jonathan G. Seidman).Discussion.The cardiomyocyte cell cycle (Pascal J. E. Lafontant and Loren J. Field).Discussion.Restoration of cardiac function with progenitor cells (Carmen Urbich, Lothar Rö ssig and Stefanie Dimmeler).Discussion.Signalling pathways in cardiac regeneration (Maria Paola Santini, Nadine Winn and Nadia Rosenthal).Discussion.Beyond small molecule drugs for heart failure: prospects for gene therapy (Kenneth R. Chien).Discussion.Dual roles of telomerase in cardiac protection and repair (Michael D. Schneider).Discussion.Final general discussion.Closing remarks: historical perspective (Arnold M. Katz).Index of contributors.Subject index. Biowissenschaften Zell- u. Molekularbiologie Cell & Molecular Biology Kardiovaskuläre Erkrankungen Life Sciences Medizin Cardiovascular Disease Biotechnologie i. d. Biowissenschaften Biotechnologie Medical Science Biotechnology, John Wiley & Sons

New book Rheinberg-Buch.de
Ebook, Englisch, Neuware Shipping costs:Ab 20¤ Versandkostenfrei in Deutschland, Sofort lieferbar, DE. (EUR 0.00)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Heart Failure - Molecules, Mechanisms and Therapeutic Targets, No. 274
book is out-of-stock
(*)
Heart Failure - Molecules, Mechanisms and Therapeutic Targets, No. 274 - new book

2006, ISBN: 0470029323

ID: 9780470029329

In englischer Sprache. Verlag: John Wiley & Sons, Introduction (Eric N. Olson). Control of cardiac hypertrophy and heart failure by histoneacetylation/deacetylation (Eric N. Olson, Johannes Backs andTimothy A. McKinsey) . Discussion. A novel mechanism of mechanical stress-induced hypertrophy(Hiroshi Akazawa, Yunzeng Zou and Issei Komuro) . Discussion. Controlling cardiomyocyte survival (N. de Jonge, M. J.Goumans, Daan Lips, Rutger Hassink, Eva J. Vlug, Roy van der Meel,Christopher Donald Emmerson, Joppe Nijman, Leon de Windt and PieterA. Doevendans) . Discussion. Mechanisms of angiotensin II-dependent progression to heartfailure (Mona Nemer, Nassim Dali-Youcef, Hao Wang, Anne Ariesand Pierre Paradis) . Discussion. Alterations in myocardial gene expression as a basis forcardiomyopathies and heart failure (Matthew R. Taylor andMichael R. Bristow) . Discussion. Role of the insulin-like growth factor 1(IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediatingphysiological cardiac hypertrophy (Julie R. McMullen and SeigoIzumo). Discussion. Role of Akt in cardiac growth and metabolism(Anthony J.Muslin and Brian DeBosch). Discussion. Novel therapy for heart failure and exercise-induced ventriculartachycardia based on 'fixing' the leak in ryanodinereceptors (Andrew R. Marks). Discussion. General discussion I. Phospholamban as a therapeutic modality in heart failure(Guoxiang Chu and Evangelia G. Kranias). Discussion. Sarcomere protein gene mutations and inherited heart disease: ab-cardiac myosin heavy chain mutation causing endocardialfibroelastosis and heart failure (Mitsuhiro Kamisago, Joachim P.Schmitt, Dennis McNamara, Christine Seidman and Jonathan G.Seidman). Discussion. The cardiomyocyte cell cycle (Pascal J. E. Lafontant andLoren J. Field). Discussion. Restoration of cardiac function with progenitor cells (CarmenUrbich, Lothar Rössig and Stefanie Dimmeler). Discussion. Signalling pathways in cardiac regeneration (Maria PaolaSantini, Nadine Winn and Nadia Rosenthal). Discussion. Beyond small molecule drugs for heart failure: prospects forgene therapy (Kenneth R. Chien). Discussion. Dual roles of telomerase in cardiac protection and repair(Michael D. Schneider). Discussion. Final general discussion. Closing remarks: historical perspective (Arnold M.Katz). Index of contributors. Subject index. PC-PDF, 302 Seiten, 302 Seiten, 1., Auflage, [GR: 9672 - Nonbooks, PBS / Biologie/Mikrobiologie], [SW: - Mikrobiologie (nicht-medizinisch) ], [Ausgabe: 1][PU:John Wiley & Sons], [PU: Wiley]

New book Libreka.de
Libreka
Shipping costs:Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Heart Failure - Wiley
book is out-of-stock
(*)
Wiley:
Heart Failure - new book

2006, ISBN: 9780470029329

ID: 5574864

Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dramatic progress has been made in unravelling the cellular circuitry involved in cardiac failure, as well as in normal cardiac growth. Heart failure is the main cause of death and disability in the industrialized world. There is a major need for novel therapeutics for prevention and reversal of cardiac pathology associated with heart failure and cardiac enlargement. Over recent years, dramatic progress has been made in unravelling the cellular circuitry involved in cardiac failure, as well as in normal cardiac growth, development and apoptosis. This work has revealed new and unexpected therapeutic targets in the heart. In addition, advances in understanding the role of stem cells in cardiac physiology have suggested strategies for cardiac repair and regeneration once thought impossible. This book describes the work of leading investigators studying the basic mechanisms of cardiac growth, function and dysfunction. There are also exciting contributions from researchers developing novel therapeutic strategies for cardiac disease. The unique feature is the discussions amongst the contributors, which always return to the same basic problem: how can new data from biological studies be used to design novel therapies for the treatment of cardiac dysfunction following myocardial infarction, hypertension and other disorders? With its strong emphasis on translational research, this book will appeal to both scientists and clinicians interested in diminishing the impact of the current epidemic of cardiac diseases. eBooks, Science & Geography~~Biology, Life Sciences~~Biochemistry, Heart Failure~~EBook~~9780470029329~~Novartis Foundation, , Heart Failure, Novartis Foundation, 9780470029329, Wiley, 11/02/2006, , , , Wiley

New book Hive.co.uk
MPN: , SKU 5574864 Shipping costs:plus shipping costs
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.
Heart Failure - John Wiley & Sons
book is out-of-stock
(*)
John Wiley & Sons:
Heart Failure - new book

2006, ISBN: 9780470029329

ID: 788735986

Heart failure is the main cause of death and disability in theindustrialized world. There is a major need for novel therapeuticsfor prevention and reversal of cardiac pathology associated withheart failure and cardiac enlargement. Over recent years, dramaticprogress has been made in unravelling the cellular circuitryinvolved in cardiac failure, as well as in normal cardiac growth,development and apoptosis. This work has revealed new andunexpected therapeutic targets in the heart. In addition, advancesin understanding the role of stem cells in cardiac physiology havesuggested strategies for cardiac repair and regeneration oncethought impossible. This book describes the work of leading investigators studyingthe basic mechanisms of cardiac growth, function and dysfunction.There are also exciting contributions from researchers developingnovel therapeutic strategies for cardiac disease. The uniquefeature is the discussions amongst the contributors, which alwaysreturn to the same basic problem: how can new data from biologicalstudies be used to design novel therapies for the treatment ofcardiac dysfunction following myocardial infarction, hypertensionand other disorders? With its strong emphasis on translational research, this bookwill appeal to both scientists and clinicians interested indiminishing the impact of the current epidemic of cardiacdiseases. Molecules, Mechanisms and Therapeutic Targets eBook PDF 02.11.2006 eBooks>Fremdsprachige eBooks>Englische eBooks>Sach- & Fachthemen>Medizin, John Wiley & Sons, .200

New book Orellfuessli.ch
No. 27973850. Shipping costs:zzgl. Versandkosten. (EUR 15.62)
Details...
(*) Book out-of-stock means that the book is currently not available at any of the associated platforms we search.